These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 1387094)

  • 1. Lp(a): a link between thrombosis and atherosclerosis.
    Scanu AM
    Eur J Epidemiol; 1992 May; 8 Suppl 1():76-8. PubMed ID: 1387094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein(a)-clinical aspects and future challenges.
    Kurt B; Soufi M; Sattler A; Schaefer JR
    Clin Res Cardiol Suppl; 2015 Apr; 10(Suppl 1):26-32. PubMed ID: 25732622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models.
    Boffa MB; Marcovina SM; Koschinsky ML
    Clin Biochem; 2004 May; 37(5):333-43. PubMed ID: 15087247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein(a): its inheritance and molecular basis of its atherothrombotic role.
    Scanu AM
    Mol Cell Biochem; 1992 Aug; 113(2):127-31. PubMed ID: 1387699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lp(a) as a marker for coronary heart disease risk.
    Scanu AM
    Clin Cardiol; 1991 Feb; 14(2 Suppl 1):I35-9. PubMed ID: 1828399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lipoprotein(a): risk factor for atherosclerotic vascular disease important to take into account in practice].
    Couderc R; Maachi M
    Ann Biol Clin (Paris); 1999; 57(2):157-67. PubMed ID: 10210742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein(a) and atherosclerosis: new perspectives on the mechanism of action of an enigmatic lipoprotein.
    Koschinsky ML
    Curr Atheroscler Rep; 2005 Sep; 7(5):389-95. PubMed ID: 16105483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lipoprotein(a): a link between thrombosis and atherosclerosis?].
    Hansen PR
    Ugeskr Laeger; 1993 May; 155(20):1527-30. PubMed ID: 8316983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein Lp(a): impact on atherosclerosis and immunochemical quantification.
    Kostner GM
    Przegl Lek; 1989; 46(7):560-2. PubMed ID: 2531445
    [No Abstract]   [Full Text] [Related]  

  • 10. Lipoprotein(a) as a risk factor for coronary artery disease.
    Marcovina SM; Koschinsky ML
    Am J Cardiol; 1998 Dec; 82(12A):57U-66U; discussion 86U. PubMed ID: 9915664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein metabolism and atherogenesis: implications for therapy.
    Kostner GM
    Cardiology; 1991; 78(3):194-201. PubMed ID: 1651161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic basis and pathophysiological implications of high plasma Lp(a) levels.
    Scanu AM
    J Intern Med; 1992 Jun; 231(6):679-83. PubMed ID: 1535652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening, diagnosis, and management of dyslipoproteinemia in children.
    Franklin FA; Brown RF; Franklin CC
    Endocrinol Metab Clin North Am; 1990 Jun; 19(2):399-449. PubMed ID: 2192880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis.
    Caplice NM; Panetta C; Peterson TE; Kleppe LS; Mueske CS; Kostner GM; Broze GJ; Simari RD
    Blood; 2001 Nov; 98(10):2980-7. PubMed ID: 11698280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein(a). A potential bridge between the fields of atherosclerosis and thrombosis.
    Scanu AM
    Arch Pathol Lab Med; 1988 Oct; 112(10):1045-7. PubMed ID: 2972266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current standards in diagnosis and therapy of hyperlipoproteinemia.
    Fischer S; Schatz U; Julius U
    Atheroscler Suppl; 2013 Jan; 14(1):15-8. PubMed ID: 23357135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein(a): a genetically determined cardiovascular pathogen in search of a function.
    Scanu AM
    J Lab Clin Med; 1990 Aug; 116(2):142-6. PubMed ID: 2144311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in the atherogenic risk of patients treated by lipoprotein apheresis according to their lipid pattern.
    von Dryander M; Fischer S; Passauer J; Müller G; Bornstein SR; Julius U
    Atheroscler Suppl; 2013 Jan; 14(1):39-44. PubMed ID: 23357139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lowering of lipoprotein(a) level under niacin treatment is dependent on apolipoprotein(a) phenotype.
    Artemeva NV; Safarova MS; Ezhov MV; Afanasieva OI; Dmitrieva OA; Pokrovsky SN
    Atheroscler Suppl; 2015 May; 18():53-8. PubMed ID: 25936305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein(a) and atherosclerosis.
    Scanu AM; Lawn RM; Berg K
    Ann Intern Med; 1991 Aug; 115(3):209-18. PubMed ID: 1829339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.